Day One Bio aims to bring new cancer therapies to pediatric patients faster amid evolving financial incentives, such as the ...
Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback